Drug Type AAV based gene therapy |
Synonyms- |
Target |
Action modulators |
Mechanism IL-2 modulators(Interleukin-2 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization- |
Active Organization- |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hepatocellular Carcinoma | Preclinical | - | - | 01 May 2024 |